These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

968 related items for PubMed ID: 21507031

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prevalence of VKORC1 and CYP2C9 gene polymorphisms in Indian population and its effect on warfarin response.
    Shalia KK, Doshi SM, Parikh S, Pawar PP, Divekar SS, Varma SP, Mehta R, Doctor T, Shah VK, Saranath D.
    J Assoc Physicians India; 2012 Dec; 60():34-8. PubMed ID: 23781667
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Development and comparison of a warfarin-dosing algorithm for Korean patients with atrial fibrillation.
    Cho HJ, On YK, Bang OY, Kim JW, Huh W, Ko JW, Kim JS, Lee SY.
    Clin Ther; 2011 Oct; 33(10):1371-80. PubMed ID: 21981797
    [Abstract] [Full Text] [Related]

  • 10. Genetic and clinical determinants influencing warfarin dosing in children with heart disease.
    Nguyen N, Anley P, Yu MY, Zhang G, Thompson AA, Jennings LJ.
    Pediatr Cardiol; 2013 Apr; 34(4):984-90. PubMed ID: 23183958
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen.
    Sconce EA, Khan TI, Wynne HA, Avery P, Monkhouse L, King BP, Wood P, Kesteven P, Daly AK, Kamali F.
    Blood; 2005 Oct 01; 106(7):2329-33. PubMed ID: 15947090
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A warfarin-dosing model in Asians that uses single-nucleotide polymorphisms in vitamin K epoxide reductase complex and cytochrome P450 2C9.
    Tham LS, Goh BC, Nafziger A, Guo JY, Wang LZ, Soong R, Lee SC.
    Clin Pharmacol Ther; 2006 Oct 01; 80(4):346-55. PubMed ID: 17015052
    [Abstract] [Full Text] [Related]

  • 15. Influence of CYP2C9 and vitamin k oxide reductase complex (VKORC)1 polymorphisms on time to determine the warfarin maintenance dose.
    Aomori T, Obayashi K, Fujita Y, Araki T, Nakamura K, Nakamura T, Kurabayashi M, Yamamoto K.
    Pharmazie; 2011 Mar 01; 66(3):222-5. PubMed ID: 21553655
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The influence of CYP2C9 and VKORC1 gene polymorphisms on optimal warfarin doses after heart valve replacement.
    Tatarūnas V, Lesauskaitė V, Veikutienė A, Jakuška P, Benetis R.
    Medicina (Kaunas); 2011 Mar 01; 47(1):25-30. PubMed ID: 21681008
    [Abstract] [Full Text] [Related]

  • 18. VKORC1 and CYP2C9 genotypes and acenocoumarol anticoagulation status: interaction between both genotypes affects overanticoagulation.
    Schalekamp T, Brassé BP, Roijers JF, Chahid Y, van Geest-Daalderop JH, de Vries-Goldschmeding H, van Wijk EM, Egberts AC, de Boer A.
    Clin Pharmacol Ther; 2006 Jul 01; 80(1):13-22. PubMed ID: 16815313
    [Abstract] [Full Text] [Related]

  • 19. Pharmacogenetic impact of VKORC1 and CYP2C9 allelic variants on warfarin dose requirements in a hispanic population isolate.
    Palacio L, Falla D, Tobon I, Mejia F, Lewis JE, Martinez AF, Arcos-Burgos M, Camargo M.
    Clin Appl Thromb Hemost; 2010 Feb 01; 16(1):83-90. PubMed ID: 19567378
    [Abstract] [Full Text] [Related]

  • 20. CYP2C9 and VKORC1 polymorphisms influence warfarin dose variability in patients on long-term anticoagulation.
    Santos PC, Dinardo CL, Schettert IT, Soares RA, Kawabata-Yoshihara L, Bensenor IM, Krieger JE, Lotufo PA, Pereira AC.
    Eur J Clin Pharmacol; 2013 Apr 01; 69(4):789-97. PubMed ID: 22990331
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.